Kraft Precision Medicine Accelerator @Harvard Business School
Reporter: Aviva Lev-Ari, PhD, RN
The mission of the Harvard Business School (HBS) Kraft Precision Medicine Accelerator is to speed medical breakthroughs in precision medicine, the process by which genomic information and other unique characteristics of a person’s disease are used to predict which treatments will be most effective.
HBS KRAFT PRECISION MEDICINE ACCELERATOR DATASET LANDSCAPE ASSESSMENT
A Key Data Sharing Partnership: The Multiple Myeloma Research Foundation Donates Data to the GDC
DRIVING DATA PARTNERSHIPS ACROSS ONCOLOGY
Framing the Data/Technology Landscape
We partnered with PricewaterhouseCoopers to conduct an exhaustive survey of large-scale genomic data sets in the public domain. This is the most comprehensive landscape analysis to date. View landscape (pdf).
Bringing Together the Best-in-Class
We convened 40 of today’s most innovative scientific, business, and technology leaders to solve key challenges in data generation, aggregation and analytics. Outputs from the meeting are widely disseminated to maximize impact. View the list the agenda (pdf) and list of attendees (pdf).
Dr. Anthony Philippakis, Chief Data Officer, The Broad Institute
Dr. Barrett Rollins, Chief Scientific Officer, DFCI, Inc.; Margaret Anderson, Executive Director, FasterCures
Dr. Nikhil Wagle and Dr. Corrie Painter, Leaders, Metastatic Breast Cancer Project
Challenging Teams to Find Solutions
HBS partnered with the Broad Institute and Crowd Innovation Lab to host a series of data challenges to accelerate precision medicine. The crowd-based challenges focus on developing optimal algorithms for faster DNA sequence alignment and optimizing inferred gene expression.View crowdsourcing challenges.
Building New Partnerships & Models
The Multiple Myeloma Research Foundation (MMRF) is the first non-profit organization to share its data with the Genomic Data Commons. The addition of the MMRF CoMMpass dataset, which includes both genomic and clinical data, will help bring the GDC achieve its goal of amassing data from 30,000 patients by year-end. Read the announcement.
DRIVING DTP EFFORTS TO ENHANCE PATIENT ENGAGEMENT & DATA SHARING
DTP & DTC Landscape
We engaged PricewaterhouseCoopers to survey the DTC and DTP landscape. Findings will be available in October 2016.
Exchanging Best Practices Between DTC Transformers & DTP Organizations
We’re uniting today’s most visionary business leaders and healthcare innovators at the Harvard i-Lab in October 2016. This exciting event will explore how DTP and DTC best practices can be applied to precision medicine.